تخطي إلى المحتوى الرئيسي
Heritable Health
Heritable Health
اشتراك
Telegenomics for the Modern Patient

Your DNA, explained by MDs and genetic counsellors.

Heritable Health generates a tier-graded DNA report from your uploaded data, then pairs it with a 30-minute video consultation with a doctor or genetic counsellor. Your consultation focuses on clinically relevant findings today and emerging evidence that may need context.

A calm clinician desk with a DNA report on a tablet, counseling notes, and medical tools
  • HIPAA-covered entity
  • Clinician-interpreted reports
  • 5-tier evidence grading
  • Encrypted, isolated data
What we do
i.

Tier-graded evidence

Every marker we surface carries an evidence tier: STRONG, VALIDATED, MODERATE, EMERGING, or EXPLORATORY. You see what’s clinically actionable today, what’s still under investigation, and where the boundary sits. No false certainty.

ii.

Clinician interpretation

Our system generates your DNA report from uploaded data. A doctor or genetic counsellor interprets the report with your goals and family history in mind, including pharmacogenomics, predispositions, and screening considerations that may be relevant to your case.

iii.

Care coordination

Where appropriate, we coordinate with your existing healthcare provider and route follow-up testing through suitable local clinical or laboratory pathways. Telegenomics supports ongoing care, but does not replace it.

How we grade evidence

Every finding carries an evidence tier.

You see what is clinically actionable today, what is still under investigation, and where the boundary sits. No false certainty.

  1. 01
    قوي
    Clinical consensus
  2. 02
    Validated
    Guideline and FDA backed
  3. 03
    معتدل
    Replicated findings
  4. 04
    Emerging
    Active research
  5. 05
    Exploratory
    Early signal

Common concerns with direct-to-consumer DNA testing.

The clinical necessity of oversight

Direct-to-consumer (DTC) genetic testing provides a broad overview of your genomic profile, yet the clinical interpretation of these findings requires professional oversight. A genetic clinician contextualizes raw data within your personal and family medical history, distinguishing between benign variations and findings that necessitate clinical action.

Professional consultation ensures that your results are understood accurately, mitigating unnecessary anxiety or false reassurance derived from automated reports.

Clinical follow-up and management

If a report identifies markers associated with hereditary conditions, such as predispositions for cardiovascular disease or oncological risks, clinical follow-up is essential. A qualified professional can determine if additional diagnostic-grade testing is required and assist in developing a proactive surveillance or management strategy tailored to your risk profile.

Heritable Health provides a necessary bridge between raw genetic data and actionable medical guidance. Our goal is to ensure your health decisions are informed by current clinical standards and the latest peer-reviewed genomic research.

We recommend scheduling a consultation if you have identified specific markers of concern or require a comprehensive review of your genetic health profile.

Important DNA markers to discuss with your doctor or genetic counselor.

  • BRCA1 and BRCA2: الجينات التي تزيد من خطر الإصابة بسرطان الثدي والمبيض، وخاصة SNPs rs80357906 (BRCA1) و rs1799950 (BRCA2).
  • MCM6: هذا المؤشر مرتبط بالاستمرار في إنتاج اللاكتاز أو عدم تحمل اللاكتوز، وبشكل خاص SNP rs4988235.
  • FTO: مرتبط بالسمنة ومرض السكري من النوع الثاني، وخاصة SNP rs9939609.
  • APOE: مرتبط بمرض الزهايمر، بما في ذلك SNPs rs429358 و rs7412.
  • TCF7L2: هذا المؤشر مرتبط بداء السكري من النوع الثاني، وخاصة SNP rs7903146.
  • OPRM1: مرتبط بالاعتماد على الأفيون والكحول، لا سيما SNP rs1799971.
  • CDKN2A/B: مرتبط بأمراض القلب التاجية، وبشكل خاص SNP rs1333049.
  • CHRNA3: مرتبطة بالاعتماد على النيكوتين، بما في ذلك SNPs rs1051730 و rs3750344.
  • CFTR: مرتبطة بالتليف الكيسي، وخاصة الطفرات ΔF508 (rs113993960) وG551D (rs113993959).
  • MTHFR: مرتبط بنقص ميثيلين تتراهيدروفولات ريدوكتاز، وخاصة SNPs rs1801133 (C677T) و rs1801131 (A1298C).
  • KCNJ11: مرتبطة بمرض السكري من النوع الثاني، وخاصة SNP rs5219 (E23K).

Some markers worth discussing.

A curated selection from the marker library. Our clinicians can help you interpret what each means in your case.

BRCA1 breast cancer 1 gene (rs55770810)

Telegenomics, by appointment.

Bring your raw DNA file. Our clinician reviews it before your call, and the conversation focuses on what’s actionable for you.

Book Your Consultation
Steps to get started

How our video consultations work.

  1. Step 1

    احجز استشارة أولية وقم بتحميل بيانات الحمض النووي الخاصة بك.

  2. Step 2

    طبيبنا يستعرض معلوماتك وقد يتابع معك ببعض الأسئلة.

  3. Step 3

    قم بإجراء مكالمات فردية مع متخصص طبي للحصول على نصائح مخصصة وإحالات.

Frequently asked questions.

ما هو التيلوجينوميات؟
كيف يمكنني حجز استشارة؟
ما هي اختبارات الحمض النووي التي تقبلونها؟
هل بياناتي الجينية آمنة؟
هل يمكنني الحصول على اختبار DNA متابعة؟
كيف تُجرى الاستشارات؟

Understanding SNPs and the human genome.

Genomic complexity and variation

The human genome is comprised of approximately 6.4 billion base pairs. While the vast majority of our genetic sequence is identical across the species, roughly 10 million positions exhibit variation between individuals. These points of difference represent the biological diversity that influences everything from physical traits to disease susceptibility.

The role of Single Nucleotide Polymorphisms

A single nucleotide polymorphism (SNP) is a variation at a specific position in the DNA sequence. As the most prevalent form of genetic variation, SNPs serve as critical biological markers. By identifying patterns in these variations, clinicians can map genetic predispositions and better understand the underlying mechanisms of various health conditions.

شرح SNP